Todos Medical Receives Approval from Israeli Ministry of Health (AMAR) to Market and Sell its Breast Cancer Screens in Israel
May 23, 2019 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, May 23, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Enters Exclusive Distribution Agreement with Care G.B. Plus, Ltd. for its Breast Cancer Screening Tests in Israel
May 21, 2019 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, May 21, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of...
Todos Medical Receives Notice of Allowance from the USPTO Covering the Early Diagnosis of Lung Cancer Using the Todos Biochemical Infrared Analysis (TBIA)
May 01, 2019 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel and NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the...
Precipio Signs First Major International Services Contract
April 29, 2019 08:35 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 29, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) today announced that it has signed a services contract with a health care...
Todos Medical Enters Into Definitive Agreement With Orot+ for Exclusive Distribution Rights of its Breast Cancer Screening Tests in 2 European Countries
April 15, 2019 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, April 15, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection...
Continued ICP Orders From Japanese Customers
March 05, 2019 07:40 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 05, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it continues to receive both new and repeat business from...
Precipio Announces First US Government Customer for ICE COLD-PCR™ Mutation Enrichment Technology
January 10, 2019 07:45 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that it has been approved by the United States Department of...
Precipio Reports Strong Mid-Quarter Growth
December 12, 2018 08:15 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that based on metrics observed in its October and November revenue...
Clinical Genomics partners with the Colorectal Cancer Alliance in the Life After Cancer Mission
November 29, 2018 08:30 ET
|
Clinical Genomics
BRIDGEWATER, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced its partnership with the...
Precipio ICE COLD-PCR™ Technology Selected by the University of Cincinnati Medical Center for Liquid Biopsy Study
November 27, 2018 09:38 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced that its ICE COLD-PCR™ (ICP) technology has been selected for a...